Mark G. Qian

Discovery of TAK-981, a First-in-Class Inhibitor of SUMO-Activating Enzyme for the Treatment of Cancer

Steven Langston, Stephen Grossman, Dylan B. England et al. · Journal of Medicinal Chemistry · 2021 · 194 citations · Full text

Determination of drug plasma protein binding by solid phase microextraction

Florin Marcel Musteata, Janusz Pawliszyn, Mark G. Qian et al. · Journal of Pharmaceutical Sciences · 2006 · 101 citations

Biochemistry, Medicine, Bioanalysis +8

A novel liquid chromatography/tandem mass spectrometry based depletion method for measuring red blood cell partitioning of pharmaceutical compounds in drug discovery

Shaoxia Yu, Shelly Li, Hua Yang et al. · Rapid Communications in Mass Spectrometry · 2004 · 95 citations

Whole Blood, Gas Chromatography, Drug Purity +17

Simultaneous On-Line Characterization of Small Organic Molecules Derived from Combinatorial Libraries for Identity, Quantity, and Purity by Reversed-Phase HPLC with Chemiluminescent Nitrogen, UV, and Mass Spectrometric Detection

Eric W. Taylor, Mark G. Qian, Gavin Dollinger · Analytical Chemistry · 1998 · 85 citations

Engineering, Combinatorial Libraries, Organic Chemistry +20

Ras-Driven Transcriptome Analysis Identifies Aurora Kinase A as a Potential Malignant Peripheral Nerve Sheath Tumor Therapeutic Target

Ami V. Patel, David Eaves, Walter J. Jessen et al. · Clinical Cancer Research · 2012 · 64 citations · Full text